For the Cause

DNA sequencing is increasingly becoming the go-to test to uncover the causes of rare genetic disorders, writes Gina Kolata at the New York Times. While parents seeking such a test for their children have high expectations, experts note that genetic mutations are only found in about a quarter of cases, and the test leads to better treatment plans in only about 3 percent of cases and improvement in about 1 percent of cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Search Here

This Week in PLOS

Clues and Questions

For the Answer

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."